Bottom line
ETAHX vs SBIO: the short answer
ETAHX (Eventide Healthcare & Life Sciences Fund) and SBIO (ALPS Medical Breakthroughs ETF) are both mutual funds.
SBIO is cheaper at 0.5% vs 1.54% — a difference of $104 a year per $10,000 invested.
Over five years, SBIO returned +0.7% a year vs −0.5% for ETAHX.
ETAHX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
ETAHX vs SBIO side by side
| ETAHX | SBIO | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Mutual | Alps |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.54% | 0.5% |
| Annual cost per $10k | $154 | $50 |
| 10-yr cost on $10k (prospectus) | $2,304 | $628 |
| Max front load | 5.75% | None |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +47.4% | +54.2% |
| 5-yr return (annualized) | −0.5% | +0.7% |
| 10-yr return (annualized) | +9.9% | +5.7% |
| Best quarter | +46.4% | +33.9% |
| Worst quarter | −24.4% | −30.8% |
| Net assets (fund) | $1.8B | $161.8M |
| Number of holdings | 93 | 89 |
| Portfolio turnover | 87% | 58% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | ETAHX | SBIO | Difference |
|---|---|---|---|
| 2025 | +56.3% | +54.2% | +2.1% |
| 2024 | −10.4% | +4.2% | −14.5% |
| 2023 | +10.8% | +8.2% | +2.6% |
| 2022 | −19.8% | −27.9% | +8.0% |
| 2021 | −16.8% | −17.5% | +0.8% |
| 2020 | +36.7% | +21.2% | +15.5% |
| 2019 | +58.3% | +49.9% | +8.4% |
| 2018 | −0.4% | −11.2% | +10.8% |
| 2017 | +45.5% | +44.9% | +0.6% |
| 2016 | −16.3% | −27.7% | +11.4% |
Source: Fund prospectus bar charts
Holdings overlap
4 of ETAHX's top 25 holdings also appear in SBIO's top 25.
| Holding | ETAHX | SBIO |
|---|---|---|
| Mirum Pharmaceuticals Inc | 3.47% | 3.90% |
| Kymera Therapeutics Inc | 3.22% | 4.23% |
| Celldex Therapeutics Inc | 2.16% | 1.33% |
| Apogee Therapeutics Inc | 1.93% | 2.93% |
Source: SEC Form N-PORT
ETAHX top 10
- Guardant Health Inc — 5.37%
- US Bank Mmda — 3.75%
- Mirum Pharmaceuticals Inc — 3.47%
- Kymera Therapeutics Inc — 3.22%
- Abivax Sa — 2.94%
- BeLite Bio Inc — 2.83%
- Trevi Therapeutics Inc — 2.77%
- Mbx Biosciences Inc — 2.70%
- Vaxcyte Inc — 2.69%
- Cytokinetics Inc — 2.69%
SBIO top 10
- Alkermes Plc — 4.48%
- Kymera Therapeutics Inc — 4.23%
- Celcuity Inc — 3.92%
- Mirum Pharmaceuticals Inc — 3.90%
- Spyre Therapeutics Inc — 3.68%
- Cg Oncology Inc — 3.35%
- Apogee Therapeutics Inc — 2.93%
- Xenon Pharmaceuticals Inc — 2.90%
- Travere Therapeutics Inc — 2.77%
- Dianthus Therapeutics Inc — 2.64%
FAQ
What is the difference between ETAHX and SBIO?
Which is cheaper, ETAHX or SBIO?
Should I own both ETAHX and SBIO?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.